Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Effectiveness of TECAR therapy with exercise for lateral epicondylitis

Official title: Effectiveness of Capacitive and Resistive Energy Transfer Therapy in Patients With Lateral Epicondylitis: A Sham-Controlled, Double-Blind Randomized Clinical Trial

Run by Gaziantep City Hospital · NCT07634224 · Data updated 2026-11-12

This randomized trial tests whether adding TECAR therapy to a standard exercise program helps reduce pain and improve function in people with tennis elbow.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment62 (estimated)
SponsorGaziantep City Hospital
Academic / other
Locations1 site (Gaziantep, Gaziantep)
StatusRecruiting
StartedMay 11, 2026
Main results expectedDecember 11, 2026
Study endsMay 11, 2027
Registry record updatedJune 11, 2026
Trial IDNCT07634224 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with unilateral lateral epicondylitis persisting at least 6 weeks and positive provocative tests, willing to participate and provide informed consent.

Probably not a fit

Patients with recent elbow injections, recent physical therapy, NSAID use within 2 weeks, prior elbow fracture or surgery, pregnancy, pacemaker or electronic implants, or other exclusion criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, randomized, double-blind, sham-controlled study compares TECAR therapy plus a home exercise program to sham TECAR plus the same exercise program in adults with lateral epicondylitis. All participants receive a structured home exercise regimen including elbow and wrist range-of-motion, stretching, eccentric strengthening, and handgrip work. Outcomes are measured by a blinded evaluator at baseline, after treatment, and at 1- and 2-month follow-ups to see if TECAR provides additional benefit in pain and function. Participants are allocated using computer-generated randomization and monitored for adherence through weekly calls and home exercise logs.

Why it matters

Potential benefit: If TECAR therapy provides added benefit, patients may experience greater pain relief and improved function when combined with exercise.

How similar studies have gone: Previous sham-controlled trials of energy-based therapies in musculoskeletal conditions have shown mixed results; this study adds randomized, blinded design to assess TECAR in lateral epicondylitis.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with lateral epicondylitis who have experienced elbow pain for at least 6 weeks and have at least two positive provocative tests (Cozen's, Mill's, or Maudsley's test).
* Age between 18 and 65 years.
* Unilateral pain and tenderness over the lateral epicondyle lasting longer than 6 weeks.
* Clinically diagnosed lateral epicondylitis.
* No cognitive impairment.
* Willingness to participate and provide informed consent.

Exclusion Criteria:

* History of interventional injection to the affected elbow within the previous 3 months.
* Receipt of physical therapy for the affected elbow within the previous 3 months.
* Regular use of nonsteroidal anti-inflammatory drugs (NSAIDs) within the previous 2 weeks.
* History of fracture or surgery involving the affected elbow.
* Presence of a chronic inflammatory disease.
* History of malignancy.
* Active infection.
* Pregnancy.
* Presence of a cardiac pacemaker or other electronic implant.
* Coagulation disorders.
* Cervical radiculopathy, entrapment neuropathy, or peripheral nerve injury.
* Body mass index (BMI) ≥ 35 kg/m².

Where it's running

  • Gaziantep City Hospital
    Gaziantep, Gaziantep, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.